Further, less severe phenotypes include intermediate PMD with patients achieving independent sitting as best motor function, pure and complicated spastic paraplegia type 2 (SPG2), the latter combining features of SGP2 and PMD with early onset and progression. The gene discussed is CLU; the disease is Spastic paraplegia type 2.